Skip to main content

Funded Studies

The Foundation supports research across basic, translational and clinical science to speed breakthroughs that can lead to the creation of new treatments and a better quality of life for people with Parkinson's disease.

Search or browse funded studies

Previously funded studies appear chronologically, with the most recent appearing first.

Filters
From
To
  • ${value}

Filter Results (2345${count})

  • Alpha-Synuclein Biology and Therapies, 2019
    How Does Alpha-synuclein Cause Neurodegeneration?

    Study Rationale:
    The protein alpha-synuclein has a central, causative role in Parkinson's disease, but we do not understand how it contributes to cell degeneration. Mutations in the gene (SNCA) that...

  • Research Grant, 2019
    Interpretation of Accelerometer Data with Deep Learning

    Study Rationale:
    In-home monitoring of the severity of Parkinson's disease (PD) may help guide therapeutic decisions and prevent life-threatening falls. Deep learning is the state-of-the-art tool for...

  • Research Grant, 2019
    Parkin-activating Small Molecules in a Model of Mitophagy

    Study Rationale:
    The protein parkin plays a critical role in the health and maintenance of the brain cells that make dopamine, which degenerate in Parkinson's disease. Scientific evidence shows that...

  • GBA Biology and Therapies, 2019
    Inflammation in People with Parkinson's and a GBA Mutation and in Their Unaffected Relatives

    Study Rationale:
    Parkinson's is a complex disease combining genetic, environmental and inflammatory causes. Mutations in the GBA gene are a leading genetic contributor to Parkinson's disease. While...

  • Biomarkers of Protein Handling/Autophagy, Exosomes and Lipid, 2019
    Extracellular Vesicles from Urine as Non-invasive Biomarkers

    Study Rationale:
    Parkinson's therapeutic development has suffered because Parkinson's symptoms develop only after significant brain degeneration has occurred, leaving significant time between disease...

  • Research Grant, 2019
    Discovery and Development of Parkin Activators as Therapies for Parkinson’s Disease

    Study Rationale:
    Impaired mitochondria are a shared feature of Parkinson's disease (PD). Thus restoration of mitochondrial function offers a therapeutic avenue to slow the progression of PD. Parkin...

Two female doctors talking in the lab.

Apply for a Grant

Our funding programs support basic, translational and clinical research from academia and industry.

See Funding Opportunities
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.